VEGFA and neovascular glaucoma: Regarding iris or retinal neovascularisation or neovascular glaucoma, anti-VEGF therapy led to a significant reduction of neovascular complications compared to the sham treatment at six months (COPERNICUS,[43,44,45] CRUISE,[29,30] Epstein et al,[36,37] GALILEO,[46][47,48] ROCC,[28] and VIBRANT[68,69]).